Researchers Find Link Between Cardiovascular Health, MSK Injuries
Advanced Ultrasound Paired With AI Diagnoses Thyroid Cancers
More Regular Mammography Screenings Improves Survival After Breast Cancer Diagnosis
COVID Variant, Severity of Illness Influence Cardiac Dysfunction
AI Predicts Breast Cancer Risk Better Than Standard Clinical Risk Model
GE HealthCare Launches Sonic DL for up to 12 Times Faster MR Imaging
Philips Adds Hyperpolarized Xenon Imaging to 3T MR With Polarean Agreement
AI Analyzes MRI Images to Help Predict Rheumatoid Arthritis
PET/CT Depicts Cardiovascular Risk in Patients with Psoriatic Arthritis Inflammation
Argon Adds New Device to Soft Tissue Biopsy Portfolio
Ezra Nets FDA Clearance for AI-Based MRI Solution
QuantalX Nets FDA Breakthrough Designation for Normal Pressure Hydrocephalus Device
AI Processing Tool for MRI Shows Changes in Brain Structure From Concussions
FDA Clears GE HealthCare’s Deep-Learning Solution for Enhanced PET/CT Image Quality
FUJIFILM Sonosite Releases All Touchscreen Point-of-Care Ultrasound
Evaluating AI for Academic and Private Healthcare Settings
LG Launches Its First Medical Monitor With IPS Black Technology
Clinical Trial Demonstrates Positive Effect Protecting DNA From Radiation Exposure
Deep-Learning Framework Developed for Super-Resolution Ultrasound
FDA Approves Radiohybrid PSMA PET Imaging Agent, POSLUMA
Dr. Richard Towbin Awarded the 2023 SPR Gold Medal
NCCN Recommends FES PET for ER+ Positive Recurrent or Metastatic Breast Cancer Patients
Shimadzu Adds Konica Minolta Glassless FPD to RF Systems
Pairing AI with Breast Density Algorithms Helps Predict Long-Term Cancer Risk
Photon-Counting CT Delivers Higher SNR, CNR Than Dual-Source CT in Infants
Siemens Healthineers and CommonSpirit Health to Acquire Block Imaging
DL-Based CAD Improves Breast Ultrasound Expertise
The Economics of AI Adoption
UCLA Health to Open Theranostics Center
Guerbet and Applied Radiology Launch Elucirem | The Reveal Image Challenge
First Patient Treated in RADIATE-VT Cardiac Radioablation Trial
MRI-Based Imaging Tool to Help Researchers Study the Brain During Swallowing
Brain MRI Analysis Software Nets FDA Clearance
Philips Introduces AI-Powered CT
Cyclotron for Alpha-Emitting Radioisotopes Launched by ACSI
Myosteatosis Increases Mortality Risk
Latest Version of ChatGPT Passes Radiology Board Exam
Reperfusion in COVID Vaccine-Naïve Patients Promotes Infarction Growth
Amino Acid PET Differentiates Recurrent Brain Metastases From Treatment-Related Changes
Showing articles tagged with PET
COVID Variant, Severity of Illness Influence Cardiac Dysfunction
PET/CT Depicts Cardiovascular Risk in Patients with Psoriatic Arthritis Inflammation
FDA Approves Radiohybrid PSMA PET Imaging Agent, POSLUMA
NCCN Recommends FES PET for ER+ Positive Recurrent or Metastatic Breast Cancer Patients
Amino Acid PET Differentiates Recurrent Brain Metastases From Treatment-Related Changes
Additional Results of Phase 3 SPOTLIGHT Trial of PET Imaging Trial Reported at AUA 2023
Active Surveillance Preferred by US Prostate Cancer Patients
Heart Inflammation After COVID Vaccine Found Only in Patients With Acute Myocarditis
Procedure Standard/Practice Guideline Published for Neuroendocrine Tumor PET Imaging
Phase III Study Reports Telix Kidney Cancer Imaging Agent Detects, Characterizes Renal Masses
Investigational PET Agent Detects Distant Metastases in Newly Diagnosed Prostate Cancer
Study Investigates Sensitivity of Radiopharmaceutical to Detect Acute Myocardial Inflammation
Mayo Clinic to Lead Study of New Radiotracer for Detecting Pancreatic Cancer
PSMA PET/MRI Accurately Predicts Prostate Cancer Recurrence Risk
Whole-Body PET Scans Highlight Complexity of Immunotherapy Response
Imaging May Improve Clinical Guidance in Immunotherapy
AI Adoption into Radiology Clinical Practice
Illuccix Now Available on High-Activity Gallium Generators
Phase III ZIRCON Study of PET Imaging Agent Meets Endpoints
First Patient Dosed in Phase IIb iPREDICT Trial for CD8 ImmunoPET
PET Radiotracer Detects Early Signs of Alzheimer’s Disease
First Patient Imaged in PSMA-Negative Prostate Cancer Trial
FDG-PET Predicts Neoadjuvant Therapy Response in Pre-Op Pancreatic Cancer Patients
Blue Earth Files for FDA Approval of Radiohybrid PSMA PET Imaging Agent
[18F]Flurpiridaz PET May Improve Coronary Artery Disease Detection
PET/MR Recommended for Diagnosing Chronic Osteomyelitis, if Available
If Available, PET/MR Recommended for Diagnosing Chronic Osteomyelitis
Reduced Myocardial Blood Flow Linked to COVID-19
First Total-Body PET Scans Completed with Illuccix For Prostate Cancer Imaging
Radialis PET Imager Receives FDA Clearance
SNMMI, ASNC Letter Leads to Aetna Coverage Reversal for Cardiac PET/CT
New Radiopharmaceutical Pair Detects, Treats Melanoma
Prostate Cancer Therapy Guidelines Need Updating
SNMMI 2022 Abstract of the Year: Radionuclide Treatment for Advanced-Stage Neuroendocrine Tumors
RefleXion, Telix Expand Prostate Cancer Treatment Partnership
Patient Enrollment Complete for Phase 3 18F-Fluciclovine PET Imaging of Recurrent Brain Mets
Clarity Receives FDA IND Approval for Phase II SAR-Bombesin Imaging Trial for Prostate Cancer
Full-Body PET Identifies Biomarkers of Joint Inflammation
New N-13 Ammonia Manufacturing Site Approved in South Florida
Additional Results From SPOTLIGHT Trial of Recurrent Prostate Cancer Announced at AUA 2022
Showing articles tagged with PET
© Anderson Publishing, Ltd. 2023 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.